| 000 | 01115 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517165349.0 | ||
| 264 | 0 | _c20180430 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1177-8881 | ||
| 024 | 7 |
_a10.2147/DDDT.S135367 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbram, Débora Moitinho | |
| 245 | 0 | 0 |
_aThe modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus. _h[electronic resource] |
| 260 |
_bDrug design, development and therapy _c2017 |
||
| 300 |
_a2171-2178 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aDendritic Cells _xenzymology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoleamine-Pyrrole 2,3,-Dioxygenase _ximmunology |
| 700 | 1 | _aFernandes, Luis Gustavo Romani | |
| 700 | 1 | _aRamos Filho, Antônio Celso Saragossa | |
| 700 | 1 | _aSimioni, Patrícia Ucelli | |
| 773 | 0 |
_tDrug design, development and therapy _gvol. 11 _gp. 2171-2178 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S135367 _zAvailable from publisher's website |
| 999 |
_c27427735 _d27427735 |
||